Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Aortic Valve Stenosis | 21 | 2024 | 1976 | 2.410 |
Why?
|
Heart Valve Prosthesis | 13 | 2023 | 1494 | 1.480 |
Why?
|
Aortic Valve | 16 | 2024 | 1934 | 1.320 |
Why?
|
Radial Artery | 3 | 2021 | 195 | 1.140 |
Why?
|
Triage | 3 | 2020 | 985 | 1.000 |
Why?
|
Heart Diseases | 4 | 2020 | 2802 | 0.900 |
Why?
|
Bioprosthesis | 4 | 2021 | 598 | 0.850 |
Why?
|
Heart Valve Prosthesis Implantation | 9 | 2024 | 1542 | 0.850 |
Why?
|
Mitral Valve Insufficiency | 5 | 2023 | 1437 | 0.840 |
Why?
|
Cardiovascular Surgical Procedures | 2 | 2020 | 192 | 0.730 |
Why?
|
Fractional Flow Reserve, Myocardial | 2 | 2022 | 310 | 0.720 |
Why?
|
Mitral Valve | 6 | 2023 | 1512 | 0.690 |
Why?
|
Coronavirus Infections | 4 | 2020 | 3136 | 0.670 |
Why?
|
Pneumonia, Viral | 4 | 2020 | 3246 | 0.660 |
Why?
|
Cardiology | 4 | 2024 | 1698 | 0.650 |
Why?
|
Coronary Stenosis | 2 | 2020 | 835 | 0.630 |
Why?
|
Coronavirus | 1 | 2020 | 156 | 0.610 |
Why?
|
Cardiac Surgical Procedures | 3 | 2021 | 3561 | 0.590 |
Why?
|
Ventricular Function, Left | 5 | 2023 | 3715 | 0.570 |
Why?
|
Drug-Eluting Stents | 3 | 2020 | 758 | 0.550 |
Why?
|
Coronary Occlusion | 3 | 2018 | 307 | 0.550 |
Why?
|
Pandemics | 4 | 2020 | 8607 | 0.440 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2014 | 124 | 0.410 |
Why?
|
Prosthesis Design | 8 | 2023 | 2127 | 0.410 |
Why?
|
Patient Selection | 4 | 2021 | 4232 | 0.410 |
Why?
|
Angioplasty, Balloon, Coronary | 3 | 2011 | 1879 | 0.380 |
Why?
|
Coronary Angiography | 7 | 2020 | 4598 | 0.380 |
Why?
|
Stroke Volume | 4 | 2023 | 5103 | 0.360 |
Why?
|
Treatment Outcome | 38 | 2023 | 64017 | 0.360 |
Why?
|
Coronary Restenosis | 3 | 2017 | 429 | 0.350 |
Why?
|
Mitral Valve Annuloplasty | 2 | 2020 | 143 | 0.300 |
Why?
|
Postoperative Complications | 8 | 2021 | 15459 | 0.290 |
Why?
|
Echocardiography, Transesophageal | 5 | 2021 | 1127 | 0.290 |
Why?
|
Catheterization | 2 | 2011 | 1467 | 0.290 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2017 | 2088 | 0.280 |
Why?
|
Coronary Artery Disease | 4 | 2022 | 6565 | 0.270 |
Why?
|
Severity of Illness Index | 7 | 2022 | 15657 | 0.250 |
Why?
|
Coronary Vessels | 4 | 2020 | 3147 | 0.250 |
Why?
|
Reoperation | 3 | 2024 | 4248 | 0.250 |
Why?
|
Prosthesis Failure | 2 | 2021 | 1213 | 0.230 |
Why?
|
Practice Guidelines as Topic | 2 | 2020 | 7355 | 0.230 |
Why?
|
Atherectomy, Coronary | 1 | 2002 | 150 | 0.210 |
Why?
|
Stents | 3 | 2018 | 3311 | 0.210 |
Why?
|
Humans | 63 | 2024 | 752741 | 0.210 |
Why?
|
Septal Occluder Device | 1 | 2021 | 128 | 0.190 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2002 | 643 | 0.170 |
Why?
|
Recurrence | 3 | 2021 | 8422 | 0.160 |
Why?
|
Ventricular Outflow Obstruction | 2 | 2018 | 275 | 0.150 |
Why?
|
Laboratories, Hospital | 1 | 2019 | 195 | 0.150 |
Why?
|
Rehabilitation Centers | 1 | 2019 | 255 | 0.150 |
Why?
|
Hospital Mortality | 4 | 2020 | 5367 | 0.150 |
Why?
|
Risk Factors | 15 | 2023 | 73094 | 0.140 |
Why?
|
Myocardial Reperfusion | 1 | 2018 | 350 | 0.140 |
Why?
|
Aged | 25 | 2022 | 165629 | 0.140 |
Why?
|
Male | 32 | 2024 | 354311 | 0.140 |
Why?
|
Echocardiography, Three-Dimensional | 1 | 2021 | 603 | 0.140 |
Why?
|
Bundle-Branch Block | 1 | 2018 | 271 | 0.130 |
Why?
|
Propensity Score | 4 | 2021 | 1828 | 0.130 |
Why?
|
Echocardiography | 3 | 2023 | 5117 | 0.130 |
Why?
|
Risk | 3 | 2024 | 9683 | 0.130 |
Why?
|
Electric Impedance | 1 | 2019 | 739 | 0.130 |
Why?
|
Consensus | 3 | 2020 | 3023 | 0.130 |
Why?
|
Stroke | 4 | 2022 | 10152 | 0.130 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2020 | 457 | 0.130 |
Why?
|
Genetic Vectors | 1 | 2005 | 3417 | 0.130 |
Why?
|
Aged, 80 and over | 16 | 2020 | 58361 | 0.120 |
Why?
|
Registries | 8 | 2023 | 8216 | 0.120 |
Why?
|
Adenosine Monophosphate | 1 | 2016 | 265 | 0.120 |
Why?
|
Observer Variation | 1 | 2020 | 2622 | 0.120 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 546 | 0.120 |
Why?
|
Ventricular Remodeling | 1 | 2022 | 1229 | 0.120 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2024 | 10057 | 0.120 |
Why?
|
Graft Occlusion, Vascular | 1 | 2017 | 550 | 0.120 |
Why?
|
Brachytherapy | 2 | 2017 | 1247 | 0.110 |
Why?
|
Occupational Health | 1 | 2020 | 807 | 0.110 |
Why?
|
Time Factors | 10 | 2020 | 40195 | 0.110 |
Why?
|
Female | 28 | 2024 | 385090 | 0.110 |
Why?
|
Disclosure | 1 | 2019 | 744 | 0.110 |
Why?
|
Workload | 1 | 2019 | 857 | 0.110 |
Why?
|
Continuity of Patient Care | 1 | 2020 | 1056 | 0.110 |
Why?
|
Infection Control | 1 | 2020 | 980 | 0.110 |
Why?
|
Thrombosis | 3 | 2017 | 3035 | 0.110 |
Why?
|
Home Care Services | 1 | 2019 | 622 | 0.110 |
Why?
|
Operating Rooms | 1 | 2019 | 822 | 0.100 |
Why?
|
American Heart Association | 1 | 2017 | 1065 | 0.100 |
Why?
|
Aortic Valve Insufficiency | 1 | 2016 | 587 | 0.100 |
Why?
|
Aorta, Abdominal | 1 | 2015 | 641 | 0.100 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2017 | 545 | 0.100 |
Why?
|
Device Removal | 1 | 2017 | 668 | 0.100 |
Why?
|
Myocardial Infarction | 3 | 2020 | 11824 | 0.100 |
Why?
|
Alloys | 1 | 2011 | 123 | 0.090 |
Why?
|
Cross Infection | 1 | 2020 | 1428 | 0.090 |
Why?
|
Recovery of Function | 2 | 2019 | 2950 | 0.090 |
Why?
|
Length of Stay | 3 | 2020 | 6355 | 0.090 |
Why?
|
Wound Closure Techniques | 1 | 2011 | 84 | 0.090 |
Why?
|
Hemostatic Techniques | 1 | 2011 | 118 | 0.090 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2014 | 433 | 0.090 |
Why?
|
Patient Discharge | 2 | 2023 | 3356 | 0.090 |
Why?
|
Coronary Artery Bypass | 1 | 2020 | 2275 | 0.090 |
Why?
|
Societies, Medical | 2 | 2020 | 3802 | 0.090 |
Why?
|
Heart Valve Diseases | 1 | 2018 | 1077 | 0.090 |
Why?
|
Drug Approval | 1 | 2016 | 786 | 0.090 |
Why?
|
Critical Care | 1 | 2002 | 2696 | 0.090 |
Why?
|
Coronary Aneurysm | 1 | 2012 | 237 | 0.090 |
Why?
|
Predictive Value of Tests | 6 | 2020 | 15164 | 0.090 |
Why?
|
Risk Assessment | 7 | 2020 | 23554 | 0.080 |
Why?
|
United States | 11 | 2022 | 70772 | 0.080 |
Why?
|
Equipment Safety | 2 | 2014 | 265 | 0.080 |
Why?
|
Hemodynamics | 4 | 2020 | 4216 | 0.080 |
Why?
|
Clinical Competence | 1 | 2024 | 4729 | 0.080 |
Why?
|
Surgical Instruments | 1 | 2011 | 397 | 0.080 |
Why?
|
Boston | 2 | 2017 | 9348 | 0.080 |
Why?
|
Coronary Disease | 1 | 2002 | 6083 | 0.080 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2014 | 977 | 0.070 |
Why?
|
Retrospective Studies | 11 | 2021 | 78758 | 0.070 |
Why?
|
Heart Ventricles | 1 | 2019 | 3845 | 0.070 |
Why?
|
Referral and Consultation | 1 | 2020 | 3573 | 0.070 |
Why?
|
Heart Failure | 2 | 2023 | 11096 | 0.070 |
Why?
|
Femoral Artery | 1 | 2011 | 846 | 0.070 |
Why?
|
Aorta, Thoracic | 1 | 2013 | 1089 | 0.070 |
Why?
|
Health Policy | 1 | 2019 | 2687 | 0.070 |
Why?
|
Hospitals | 1 | 2020 | 3986 | 0.070 |
Why?
|
Patient Readmission | 1 | 2020 | 3161 | 0.070 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 1 | 2007 | 267 | 0.070 |
Why?
|
Incidence | 4 | 2020 | 21146 | 0.060 |
Why?
|
Endovascular Procedures | 1 | 2018 | 2032 | 0.060 |
Why?
|
Pulmonary Artery | 1 | 2013 | 1944 | 0.060 |
Why?
|
Clinical Trials as Topic | 3 | 2023 | 7970 | 0.060 |
Why?
|
Tissue Plasminogen Activator | 1 | 2010 | 1272 | 0.060 |
Why?
|
Angina Pectoris | 1 | 2007 | 984 | 0.060 |
Why?
|
Follow-Up Studies | 5 | 2022 | 39223 | 0.050 |
Why?
|
Hypertension, Pulmonary | 1 | 2013 | 1554 | 0.050 |
Why?
|
Peripheral Vascular Diseases | 1 | 2005 | 549 | 0.050 |
Why?
|
Middle Aged | 13 | 2022 | 216054 | 0.050 |
Why?
|
Equipment Design | 2 | 2014 | 3589 | 0.050 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 2002 | 481 | 0.050 |
Why?
|
Angioplasty, Balloon | 1 | 2005 | 654 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 1 | 2023 | 20346 | 0.050 |
Why?
|
Thrombolytic Therapy | 1 | 2010 | 2202 | 0.050 |
Why?
|
Pericardiocentesis | 1 | 2020 | 74 | 0.050 |
Why?
|
Defibrillators, Implantable | 1 | 2010 | 1464 | 0.040 |
Why?
|
Safety | 1 | 2005 | 1179 | 0.040 |
Why?
|
Fibrinolytic Agents | 1 | 2010 | 2197 | 0.040 |
Why?
|
Platelet Count | 1 | 2002 | 784 | 0.040 |
Why?
|
Survival Rate | 3 | 2019 | 12802 | 0.040 |
Why?
|
Multivariate Analysis | 3 | 2020 | 12250 | 0.040 |
Why?
|
Platelet Transfusion | 1 | 2002 | 318 | 0.040 |
Why?
|
Hospitalization | 1 | 2019 | 10422 | 0.040 |
Why?
|
Coronary Thrombosis | 1 | 2002 | 495 | 0.040 |
Why?
|
Hospital Units | 1 | 2020 | 141 | 0.040 |
Why?
|
Suction | 1 | 2020 | 268 | 0.040 |
Why?
|
Fibroblast Growth Factors | 1 | 2005 | 880 | 0.040 |
Why?
|
Cardiovascular Diseases | 1 | 2005 | 15433 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 13042 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2012 | 3511 | 0.040 |
Why?
|
Resource Allocation | 1 | 2020 | 338 | 0.040 |
Why?
|
Neovascularization, Physiologic | 1 | 2005 | 1355 | 0.040 |
Why?
|
Aerosols | 1 | 2020 | 627 | 0.040 |
Why?
|
Thrombectomy | 1 | 2002 | 713 | 0.040 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 253 | 0.040 |
Why?
|
Aftercare | 1 | 2023 | 885 | 0.040 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2022 | 552 | 0.030 |
Why?
|
North America | 1 | 2019 | 1255 | 0.030 |
Why?
|
Pressure | 1 | 2019 | 1207 | 0.030 |
Why?
|
Aortography | 1 | 2018 | 439 | 0.030 |
Why?
|
Postoperative Care | 1 | 2002 | 1497 | 0.030 |
Why?
|
Intraoperative Period | 1 | 2016 | 517 | 0.030 |
Why?
|
Fluoroscopy | 1 | 2020 | 935 | 0.030 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2017 | 364 | 0.030 |
Why?
|
Prosthesis Implantation | 1 | 2020 | 643 | 0.030 |
Why?
|
Logistic Models | 3 | 2016 | 13441 | 0.030 |
Why?
|
Embolic Protection Devices | 1 | 2014 | 42 | 0.030 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2010 | 3123 | 0.030 |
Why?
|
Injections, Intravenous | 1 | 2016 | 1420 | 0.030 |
Why?
|
Pacemaker, Artificial | 1 | 2020 | 830 | 0.030 |
Why?
|
Myocardial Ischemia | 1 | 2005 | 2152 | 0.030 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2018 | 846 | 0.030 |
Why?
|
Research | 1 | 2002 | 2001 | 0.030 |
Why?
|
Hospital Costs | 1 | 2020 | 983 | 0.030 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2003 | 1411 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2005 | 3512 | 0.030 |
Why?
|
Purinergic P2Y Receptor Antagonists | 1 | 2016 | 370 | 0.030 |
Why?
|
Medicare | 2 | 2022 | 6670 | 0.030 |
Why?
|
Critical Pathways | 1 | 2017 | 482 | 0.030 |
Why?
|
Massachusetts | 2 | 2017 | 8721 | 0.030 |
Why?
|
Autopsy | 1 | 2017 | 1024 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2017 | 1859 | 0.030 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2020 | 1005 | 0.030 |
Why?
|
Intubation, Intratracheal | 1 | 2020 | 1370 | 0.020 |
Why?
|
Aspirin | 1 | 2002 | 3332 | 0.020 |
Why?
|
Prospective Studies | 3 | 2022 | 53863 | 0.020 |
Why?
|
Lung Diseases | 1 | 2020 | 1890 | 0.020 |
Why?
|
Adult | 6 | 2023 | 216658 | 0.020 |
Why?
|
Hypertension | 2 | 2020 | 8614 | 0.020 |
Why?
|
Anastomosis, Surgical | 1 | 2013 | 994 | 0.020 |
Why?
|
Perioperative Care | 1 | 2016 | 1016 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2002 | 3717 | 0.020 |
Why?
|
Vena Cava, Superior | 1 | 2010 | 201 | 0.020 |
Why?
|
Ultrasonography, Interventional | 1 | 2017 | 1508 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2016 | 1611 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6542 | 0.020 |
Why?
|
Quality of Health Care | 1 | 2023 | 4385 | 0.020 |
Why?
|
Benchmarking | 1 | 2013 | 1048 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2017 | 1984 | 0.020 |
Why?
|
Pilot Projects | 1 | 2020 | 8413 | 0.020 |
Why?
|
Adolescent | 3 | 2023 | 86713 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2022 | 6364 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2012 | 2376 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10450 | 0.020 |
Why?
|
Angiography | 1 | 2011 | 1640 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2002 | 9300 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10469 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2010 | 2289 | 0.020 |
Why?
|
Biopsy | 1 | 2017 | 6771 | 0.020 |
Why?
|
Tomography, Optical Coherence | 1 | 2017 | 2756 | 0.020 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2007 | 584 | 0.020 |
Why?
|
Cohort Studies | 2 | 2021 | 40939 | 0.010 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2007 | 647 | 0.010 |
Why?
|
Injections | 1 | 2007 | 842 | 0.010 |
Why?
|
Electric Countershock | 1 | 2007 | 534 | 0.010 |
Why?
|
Vascular Surgical Procedures | 1 | 2013 | 1478 | 0.010 |
Why?
|
Heart Atria | 1 | 2010 | 1356 | 0.010 |
Why?
|
Cell Count | 1 | 2007 | 1856 | 0.010 |
Why?
|
Quality of Life | 2 | 2019 | 13044 | 0.010 |
Why?
|
Exercise Tolerance | 1 | 2007 | 776 | 0.010 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2007 | 1101 | 0.010 |
Why?
|
Chronic Disease | 1 | 2017 | 9223 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 5799 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2013 | 3652 | 0.010 |
Why?
|
Heart Defects, Congenital | 1 | 2018 | 4638 | 0.010 |
Why?
|
Cardiovascular Agents | 1 | 2007 | 854 | 0.010 |
Why?
|
Hemorrhage | 1 | 2011 | 3530 | 0.010 |
Why?
|
Forecasting | 1 | 2008 | 2956 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2014 | 14219 | 0.010 |
Why?
|
Medication Adherence | 1 | 2010 | 2099 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2018 | 25903 | 0.010 |
Why?
|
Health Surveys | 1 | 2008 | 4050 | 0.010 |
Why?
|
Ultrasonography | 1 | 2010 | 6037 | 0.010 |
Why?
|
Algorithms | 1 | 2017 | 13984 | 0.010 |
Why?
|
Infant | 1 | 2018 | 35447 | 0.010 |
Why?
|
Child, Preschool | 1 | 2018 | 41390 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2002 | 35798 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2007 | 8660 | 0.010 |
Why?
|
Anticoagulants | 1 | 2010 | 4738 | 0.010 |
Why?
|
Myocardium | 1 | 2007 | 4719 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2011 | 21904 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2007 | 12202 | 0.010 |
Why?
|
Young Adult | 1 | 2018 | 57267 | 0.010 |
Why?
|
Age Factors | 1 | 2008 | 18460 | 0.010 |
Why?
|
Child | 1 | 2018 | 78594 | 0.010 |
Why?
|